In B-cell chronic lymphocytic leukaemia chromosome 17 abnormalities and not trisomy 12 are the single most important cytogenetic abnormalities for the prognosis: A cytogenetic and immunophenotypic study of 480 unselected newly diagnosed patients

Leukemia Research

Volumn 21, Issue 11-12, 1997, Pages 1011-1023

  Geisler, C H ^a,b   Philip, P ^a   Christensen, B Egelund ^d   Hou Jensen, K ^a   Tinggaard Pedersen, N ^d   Myhre Jensen, O ^e   Thorling, K ^e   Andersen, E ^f   Birgens, H S ^c   Drivsholm, A ^a   Ellegaard, J ^e   Larsen, J K ^b   Plesner, T ^a   Brown, P ^a   Kragh Andersen, P ^g   Mork Hansen M ^a  

^a Rigshospitalet   (Denmark)

^b FINSEN LABORATORY   (Denmark)

^c GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^d ODENSE UNIVERSITY HOSPITAL   (Denmark)

^e AARHUS UNIVERSITY HOSPITAL   (Denmark)

^f VIBORG HOSPITAL   (Denmark)

^g UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

+12; 17p; B CLL; Cytogenetics; Immunophenotype; Prognosis

Indexed keywords

ARTICLE; B CELL LEUKEMIA; CANCER GENETICS; CANCER SURVIVAL; CHROMOSOME 12; CHROMOSOME 13Q; CHROMOSOME 14Q; CHROMOSOME 17; CHROMOSOME 6Q; CHROMOSOME ABERRATION; CHROMOSOME G BAND; CHRONIC LYMPHATIC LEUKEMIA; CYTOGENETICS; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; KARYOTYPE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; TRISOMY;

AGED; BONE MARROW; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 12; CHROMOSOMES, HUMAN, PAIR 17; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOPHENOTYPING; KARYOTYPING; LEUKEMIA, B-CELL, CHRONIC; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TRISOMY;

EID: 0031467237     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(97)00095-7     Document Type: Article

References (30)

1. Juliusson, G., Oscier, D. G., Fitchett, M., Ross, F. M., Stockdill, G., Mackie, M. J., Parker, A. C., Castoldi, G. L., Cuneo, A., Knuutila, S., Elonen, E. and Gahrton, G., Prognostic subgroups in B-cell chronic lymphocytic leukaemia defined by specific chromosome abnormalities. N. Engl. J. Med., 1990, 323, 720.
2. Juliusson, G., Gahrton, G., Oscier, D., Fitchett, M., Ross, F., Brito-Bapapulle, V., Catovsky, D., Knuutila, S., Elonen, E., Lechleitner, M., Tanzer, J., Schoenwald, M., Castoldi, G. L., Cuneo, A., Nowell, P., Peterson, L. and Kay, N., Cytogenetic findings and survival in B-cell chronic lymphocytic leukemia. Second IWCCLL compilation of data on 662 patients. Leuk. and Lymph., 1991, (Suppl. 1) 21.
3. Geisler, C. H., Philip, P. and Hansen, M. M., B-cell chronic lymphocytic leukaemia: clonal chromosome abnormalities and prognosis in 89 cases. Eur. J. Haematol., 1989, 43, 397.
4. Criel, A., Wlodarska, I., Meeus, P., Stul, M., Louwagie, A., van Hoof, A., Hidajat, M., Mecucci, C. and Van Den Berghe, H., Trisomy 12 is uncommon in typical chronic lymphocytic leukaemia. Br. J. Haematol., 1994, 87, 523.
5. Oscier, D. G., Cytogenetic and Molecular abnormalities in chronic lymphocytic leukaemia. Blood Rev., 1994, 8, 88.
6. Matutes, E., Oscier, D., Garcia-Marco, J., Ellis, J., Copplestone, A., Gillingham, R., Hamblin, T., Lens, D., Swansbury, G. J. and Catovsky, D., Trisomy 12 defines a group of CLL with atypical morphology: correlation between cytogenetic, clinical and laboratory features in 544 patients. Br. J. Haematol., 1996, 92, 365.
7. F. Mitelman (ed.), ISCN: An International System for Human Cytogenetic Nomenclature. S. Karger, Basel, 1995.
8. Geisler, C. H., Hou-Jensen, K., Myhre Jensen, O., Tinggaard-Pedersen, N., Hansen, M. M., Hansen, N. E., Holm, M., Christensen, B. E., Drivsholm, A., Boye Nielsen, J., Thorling, K., Andersen, E., Larsen, J. K. and Kragh Andersen P. for the Danish CLL Study Group. The bone marrow infiltration pattern in B-cell chronic lymphocytic leukemia is not an important prognostic factor. Eur. J. Haematol., 1996, 57, 292.
9. Geisler, C. H., Larsen, J. K., Hansen, N. E., Hansen, M. M., Christensen, B. E., Lund, B., Nielsen, H., Plesner, T., Thorling, K., Andersen, E. and Andersen, P. K., The CLL2-study: prognostic importance of flow cytometric immunophenotyping of 540 consecutive patients with B-cell chronic lymphocytic leukemia. Blood, 1991, 78, 1795.
10. Binet, J.-L., Catovsky, D., Chandra, P., Montserrat, E., Rai, K. and Sawitsky, A. (Writing committee of the international workshop on CLL), Chronic lymphocytic leukaemia: proposals for a revised staging system. Br. J. Haematol., 1981, 48, 365.
11. Hansen, M. M., Andersen, E., Christensen, B. E., Christiansen, I., Geisler, C., Kristensen, D., Jensen, K. B. and Junker, P., CHOP vs chlorambucil + prednisolone in chronic lymphocytic leukemia. Leuk. Lymph., 1991, (Suppl.), 97.
12. Kaplan, E. and Meier, E., Non-parametric estimations from incomplete observations. J. Am. Stat. Soc., 1958, 153, 457.
13. Peto, R., Pike, M. C., Armitage, P., Breslow, N. E., Cox, D. R., Howard, V., Mantel, N., McPherson, K., Peto, J. and Smith, P. G., Design and analysis of randomized trials requiring prolonged observations of each patient: II analysis and examples. Br. J. Cancer, 1977, 35, 1.
14. Cox, D. R., Regression models and life tables. J. R. Stat. Soc., 1972, B 34, 187.
15. Losada, A. P., Wessman, M., Tiainen, M., Hopman, A. H.N., Willard, H. F., Solé, F., Caballin, M. R., Woessner, S. and Knuutila, S., Trisomy 12 in chronic lymphocytic leukemia: an interphase cytogenetic study. Blood, 1991, 78, 775.
16. Rhagoebier, S., Kibbelaar, R. E., Kleiverda, J. K., Kluin-Nelemans, J. C., van Krieken, J. H. J. M., Kok, F. and Kluin, P. M., Mosaicism of trisomy 12 in chronic lymphocytic leukemia detected by non-radioactive in situ hybridization. Leukemia, 1992, 6, 1220.
17. Que, T. H., Marco, J. G., Ellis, J., Matutes, E., Brito Bapapulle, V., Boyle, S. and Catovsky, D., Trisomy 12 in chronic lymphocytic leukemia detected by fluorescence in situ hybridization: analysis by stage, immmunophenotype and morphology. Blood, 1993, 82, 571.
18. Reining, G., Clodi, K., König, M., Geissler, K., Haas, O. A. and Mannhalter, C., Detection of trisomy 12 in chronic lymphocytic leukaemia: comparison of a polymerase chain reaction based technique with fluorescence in situ hybridization. Br. J. Haematol., 1994, 87, 843.
19. Jabbar, S., Ganeshaguru, K., Wickremasinghe, R. G., Hoffbrand, A. V. and Foroni, L., Deletion of chromosome 13 (band q14) but not trisomy 12 is a clonal event in B-chronic lymphocytic leukaemia (CLL). Br. J. Haematol., 1995, 90, 476.
20. Su'ut, L., O'Connor, S., Jones, R.A., Richards, S., Jack, A.S. and Morgan, G.J., Immunophenotypic characterisation of B-cell lymphoproliferative disorders with an additional copy of chromosome 12. Blood, Suppl. 1, 1996, 88, 237a.
21. Hjalmar, B., Arvidsson, I., Östlund, L., Wallvik, J., Jakobsson, B., Hast, R. and Kimby, E., The incidence of trisomi 12 in an unselected group of patients with low-grade non-Hodgkin's lymphoma. Nordic Haematological Spring Meeting (abstract), 1996.
22. Woessner, S., Solé, F., Pérez-Losada, A., Florensa, L. and Vilá, R. M., Trisomy 12 is a rare cytogenetic event in typical chronic lymphocytic leukemia. Leuk. Res., 1996, 20, 369.
23. Garand, R., Moreau, A., Robillard, N., Gaillard, F., Accard, F. and Bataille, R., Immunophenotype profiles of 691 cases of chronic B-cell lymphoproliferative disorders (CBLPD) in leukemic phase classified according to morphologic (FAB and REAL) criteria. Blood, suppl. 1, 1996, 88, 241a.
24. Gahn, B., Schäfer, C., Neef, J., Troff, C., Feuring-Buske, M., Hiddemann, W. and Wörmann, B., Detection of leukemia-associated genetic markers in CD34 positive progenitor cells of patients with B-CLL. Blood, suppl. 1, 1996, 88, 237a.
25. Mould, S., Gardiner, A., Corcoran, M. and Oscier, D. G., Trisomy 12 and abnormalities of 13q14 occurring in the same clone in chronic lymphocytic leukaemia. Br. J. Haematol., 1996, 92, 389.
26. Liu, Y., Hermanson, M., Grandér, M., Merup, M., Wu, X., Heyman, M., Rasool, O., Juliusson, G., Gahrton, G., Detlofsson, R., Nikiforova, N., Buys, C., Söderhäll, S., Yankovsky, N., Zabaravsky, E. and Einhorn, S., 13q deletions in lymphoid malignancies. Blood, 1995, 86, 1911.
27. Watanabe, T., Hotta, T., Ichikawa, A., Kinoshita, T., Nagai, H., Uchida, T., Murate, T. and Saito, H., The MDM2 oncogene overexpression in chronic lymphocytic leukemia and low-grade lymphoma of B-cell origin. Blood, 1994, 84, 3158.
28. Delmer, A., Ajchenbaum-Cymbalista, F., Tang, R., Ramond, S., Faussat, A. M., Marie, J. P. and Zittoun, R., Overexpression of cyclin D2 in chronic B-cell malignancies. Blood, 1995, 85, 2870.
29. Döhner, H., Fischer, K., Bentz, M., Hansen, K., Benner, A., Cabot, G., Diehl, D., Schlenk, R., Coy, J., Stilgenbauer, S., Volkmann, M., Galle, P. R., Poustka, A. M., Hunstein, W. and Lichter, P., p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias. Blood, 1995, 85, 1580.
30. El Rouby, S., Thomas, A., Costin, D., Rosenberg, C. R., Potmesil, M., Silber, R. and Newcomb, E. W., p53 gene mutation in B-cell chronic lymphocytic leukemia is associated with drug resistance and is independent of MDR1/MDR3 gene expression. Blood, 1993, 82, 3452.